Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals. (original) (raw)

Mihaylova, B, Briggs, AH ORCID logoORCID: https://orcid.org/0000-0002-0777-1997, Armitage, J, Parish, S, Gary, A and Collins, R(2005) Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.Lancet, 365(9473), pp. 1779-1785.

Full text not currently available from Enlighten.

Item Type: Articles
Status: Published
Refereed: Yes
Glasgow Author(s) Enlighten ID: Briggs, Professor Andrew
Authors: Mihaylova, B., Briggs, A., Armitage, J., Parish, S., Gary, A., and Collins, R.
College/School: College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Health Economics and Health Technology AssessmentCollege of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Centre for Population and Health Sciences
Journal Name: Lancet

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details

ID Code: 22469
Depositing User: Mr Adam Field
Datestamp: 19 Dec 2009 16:05
Last Modified: 20 Sep 2018 10:17
Date of first online publication: 2005